Skip to Main Content

Author Details

Christopher W Seymour
University of Pittsburgh
2003
137
43
PMIDPaper TitleJournal TitlePublished Year
36806800The Ethics of Clinical Research: Managing Persistent Uncertainty.JAMA2023
37888913Simvastatin in Critically Ill Patients with Covid-19.N Engl J Med2023
37877585Intravenous Vitamin C for Patients Hospitalized With COVID-19: Two Harmonized Randomized Clinical Trials.JAMA2023
37322546Time to treatment and mortality for clinical sepsis subtypes.Crit Care2023
37011399Evolving Real-World Effectiveness of Monoclonal Antibodies for Treatment of COVID-19 : A Cohort Study.Ann Intern Med2023
37039790Effect of Angiotensin-Converting Enzyme Inhibitor and Angiotensin Receptor Blocker Initiation on Organ Support-Free Days in Patients Hospitalized With COVID-19: A Randomized Clinical Trial.JAMA2023
37329332Caring for Patients With Acute Respiratory Distress Syndrome: Summary of the 2023 ESICM Practice Guidelines.JAMA2023
36542339The association between prehospital HMGB1 and sepsis in emergency care.Eur J Emerg Med2023
34644242The Epidemiology of Extremity Threat and Amputation after Vasopressor-Dependent Sepsis.Ann Am Thorac Soc2022
35412625Association of Subcutaneous or Intravenous Administration of Casirivimab and Imdevimab Monoclonal Antibodies With Clinical Outcomes in Adults With COVID-19.JAMA Netw Open2022
35412128Characterizing systematic challenges in sample size determination for sepsis trials.Intensive Care Med2022
35379946Developing a shared sepsis data infrastructure: a systematic review and concept map to FHIR.NPJ Digit Med2022
35834252Effectiveness of Casirivimab-Imdevimab and Sotrovimab During a SARS-CoV-2 Delta Variant Surge: A Cohort Study and Randomized Comparative Effectiveness Trial.JAMA Netw Open2022
35697146The comparative effectiveness of COVID-19 monoclonal antibodies: A learning health system randomized clinical trial.Contemp Clin Trials2022
35830181Association Between Time to Source Control in Sepsis and 90-Day Mortality.JAMA Surg2022
35715504Redefining critical illness.Nat Med2022
36470834Sepsis biomarkers and diagnostic tools with a focus on machine learning.EBioMedicine2022
36205995Association Between Preexisting Heart Failure With Reduced Ejection Fraction and Fluid Administration Among Patients With Sepsis.JAMA Netw Open2022
36195915Circulating hypoxia-dependent miR-210 is increased in clinical sepsis subtypes: A cohort study.J Transl Med2022
35945618Clinical sepsis phenotypes in critically ill COVID-19 patients.Crit Care2022
36375150Monoclonal Antibodies for Treatment of SARS-CoV-2 Infection During Pregnancy : A Cohort Study.Ann Intern Med2022
35315874Effect of Antiplatelet Therapy on Survival and Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.JAMA2022
35325636Consensus Current Procedural Terminology Code Definition of Source Control for Sepsis.J Surg Res2022
34896293Launching a comparative effectiveness adaptive platform trial of monoclonal antibodies for COVID-19 in 21 days.Contemp Clin Trials2022
32809135A cooperation of the doves.Intensive Care Med2021
33872042Treatment Patterns and Clinical Outcomes After the Introduction of the Medicare Sepsis Performance Measure (SEP-1).Ann Intern Med2021
33620384Hydrocortisone, Vitamin C, and Thiamine for Treatment of Sepsis: Making Evidence Matter.JAMA2021
33591001Sepsis Subclasses: A Framework for Development and Interpretation.Crit Care Med2021
33616663Feasibility of Embedding a Scalable, Virtually Enabled Biorepository in the Electronic Health Record for Precision Medicine.JAMA Netw Open2021
34529626The authors reply.Crit Care Med2021
34606578Effect of Convalescent Plasma on Organ Support-Free Days in Critically Ill Patients With COVID-19: A Randomized Clinical Trial.JAMA2021
34351721Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19.N Engl J Med2021
34351722Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19.N Engl J Med2021
34250192Impact of Bamlanivimab Monoclonal Antibody Treatment on Hospitalization and Mortality Among Nonhospitalized Adults With Severe Acute Respiratory Syndrome Coronavirus 2 Infection.Open Forum Infect Dis2021
33961002Precision Medicine for COVID-19: Phenotype Anarchy or Promise Realized?JAMA2021
34034784The UPMC OPTIMISE-C19 (OPtimizing Treatment and Impact of Monoclonal antIbodieS through Evaluation for COVID-19) trial: a structured summary of a study protocol for an open-label, pragmatic, comparative effectiveness platform trial with response-adaptive randomization.Trials2021
33320841A road map from single-cell transcriptome to patient classification for the immune response to trauma.JCI Insight2021
31046502Strategy to Identify Paramedic Transported Sepsis Cases in an Emergency Department Administrative Database.Prehosp Emerg Care2020
31954465Global, regional, and national sepsis incidence and mortality, 1990-2017: analysis for the Global Burden of Disease Study.Lancet2020
32095848Prehospital identification of community sepsis using biomarkers of host response.Intensive Care Med2020
33057573Sensible Medicine-Balancing Intervention and Inaction During the COVID-19 Pandemic.JAMA2020
33298134A manifesto for the future of ICU trials.Crit Care2020
33180115COVID-19 Infection-Preventing Clinical Deterioration.JAMA2020
32805047Pharmacologic Prehabilitation-What About "the Polypill"?JAMA Surg2020
32994242Strategies to Promote ResiliencY (SPRY): a randomised embedded multifactorial adaptative platform (REMAP) clinical trial protocol to study interventions to improve recovery after surgery in high-risk patients.BMJ Open2020
32150460Identifying Clinical Research Priorities in Adult Pulmonary and Critical Care. NHLBI Working Group Report.Am J Respir Crit Care Med2020
32267474Association Between Preoperative Metformin Exposure and Postoperative Outcomes in Adults With Type 2 Diabetes.JAMA Surg2020
31180262Association Between Intravenous Fluid Bolus and Biomarker Trajectory During Prehospital Care.Prehosp Emerg Care2020
30431493Variation in Identifying Sepsis and Organ Dysfunction Using Administrative Versus Electronic Clinical Data and Impact on Hospital Outcome Comparisons.Crit Care Med2019
31779663Murine sepsis phenotypes and differential treatment effects in a randomized trial of prompt antibiotics and fluids.Crit Care2019
  • 1 - 50 of 137

Recommended Authors

Gabriel Wardi
university of california san diego
Career Start Year 2014
Number of shared co-authors 1
Daniel J Henning
University of Washington
Career Start Year 2013
Number of shared co-authors 15
Andre L Holder
Emory University
Career Start Year 2013
Number of shared co-authors 11
Markos G Kashiouris
Virginia Commonwealth University
Career Start Year 2012
Number of shared co-authors 3
Andrew J Goodwin
Medical University of South Carolina
Career Start Year 2012
Number of shared co-authors 6
Pablo Moreno Franco
Mayo Clinic
Career Start Year 2012
Number of shared co-authors 0
Michael J Lanspa
intermountain medical center
Career Start Year 2012
Number of shared co-authors 30
Nicholas M Mohr
University of Iowa Carver College of Medicine
Career Start Year 2011
Number of shared co-authors 15
Peter C Hou
Harvard Medical School, Brigham and Women's Hospital
Career Start Year 2010
Number of shared co-authors 30
Philippe R Bauer
Mayo Clinic
Career Start Year 2010
Number of shared co-authors 7
Rahul Kashyap
Mayo Clinic
Career Start Year 2008
Number of shared co-authors 11
George L Anesi
University of Pennsylvania Perelman School of Medicine
Career Start Year 2008
Number of shared co-authors 9
Raghu R Seethala
Brigham and Women's Hospital
Career Start Year 2008
Number of shared co-authors 6
Patrick G Lyons
Siteman Cancer Center, Washington University School of Medicine in St. Louis
Career Start Year 2008
Number of shared co-authors 11
Matthew C Exline
Ohio State University Wexner Medical Center
Career Start Year 2006
Number of shared co-authors 32
Robert Sherwin
Wayne State University School of Medicine Detroit Medical Center/Sinai-Grace Hospital
Career Start Year 2006
Number of shared co-authors 21
Christopher J Tignanelli
Department of Surgery University of Minnesota Minneapolis Minnesota USA.
Career Start Year 2005
Number of shared co-authors 6
David N Hager
Johns Hopkins University
Career Start Year 2005
Number of shared co-authors 25
Ithan D Peltan
Intermountain Medical Center and University of Utah
Career Start Year 2004
Number of shared co-authors 20
Samuel M Brown
Intermountain Medical Center and the University of Utah
Career Start Year 2002
Number of shared co-authors 48
Ognjen Gajic
Mayo Clinic
Career Start Year 2002
Number of shared co-authors 34
Michael R Filbin
Massachusetts General Hospital
Career Start Year 2001
Number of shared co-authors 26
Michael D Howell
Google Health
Career Start Year 2001
Number of shared co-authors 13
Tamas Szakmany
Aneurin Bevan University Health Board
Career Start Year 2000
Number of shared co-authors 11
Matthew M Churpek
University of Wisconsin-Madison
Career Start Year 2000
Number of shared co-authors 16
Henry E Wang
The Ohio State University College of Medicine
Career Start Year 1999
Number of shared co-authors 19
Marie-Carmelle Elie
University of Florida Health Shands Hospital
Career Start Year 1997
Number of shared co-authors 2
Stephen L Jones
Center for Outcomes Research
Career Start Year 1995
Number of shared co-authors 0
Ari Moskowitz
Harvard Medical School
Career Start Year 1995
Number of shared co-authors 19
Jay S Steingrub
University of Massachusetts Medical School - Baystate
Career Start Year 1985
Number of shared co-authors 42

Collaborators

Derek C Angus
University of Pittsburgh Medical Center
Co-authored papers 74
Jason N Kennedy
Clinical Research
Co-authored papers 21
Donald M Yealy
University of Pittsburgh School of Medicine
Co-authored papers 21
Jeremy M Kahn
University of Pittsburgh School of Medicine
Co-authored papers 20
Colin R Cooke
Institute for Healthcare Policy and Innovation, University of Michigan ann arbor
Co-authored papers 15
David T Huang
University of Pittsburgh School of Medicine
Co-authored papers 12
John C Marshall
St. Michael's Hospital
Co-authored papers 11
Manu Shankar-Hari
King's College London
Co-authored papers 10
Anna McGlothlin
Berry Consultants LLC
Co-authored papers 10
Theodore J Iwashyna
University of Michigan Michigan Medicine ann arbor
Co-authored papers 10
Christian Martin-Gill
University of Pittsburgh School of Medicine
Co-authored papers 10
Chung-Chou H Chang
Graduate School of Public Health, University of Pittsburgh
Co-authored papers 9
Djillali Annane
The George Institute for Global Health
Co-authored papers 9
Clifton W Callaway
University of Pittsburgh School of Medicine
Co-authored papers 9
Matthew R Rosengart
University of Pittsburgh
Co-authored papers 9
Scott M Berry
University of Kansas Medical Center
Co-authored papers 9
Matthew D Neal
University of Pittsburgh Medical Center
Co-authored papers 8
Anthony C Gordon
Imperial College London
Co-authored papers 7
Sachin Yende
Clinical Research
Co-authored papers 7
Greg S Martin
Emory University School of Medicine
Co-authored papers 7
Kathryn M Rowan
Intensive Care National Audit & Research Centre (ICNARC)
Co-authored papers 7
Srinivas Murthy
University of British Columbia
Co-authored papers 6
Alexis F Turgeon
Universite Laval
Co-authored papers 6
Tom van der Poll
Center for Experimental and Molecular Medicine, University of Amsterdam
Co-authored papers 6
Graham M Snyder
University of Pittsburgh School of Medicine
Co-authored papers 6
Octavia M Peck Palmer
University of Pittsburgh School of Medicine
Co-authored papers 6
Yaseen M Arabi
King Saud bin Abdulaziz Medical City for Science and Technology
Co-authored papers 6
Boyd Taylor Thompson
Massachusetts General Hospital, Harvard School of Medicine,
Co-authored papers 6
David J Wallace
University of Pittsburgh School of Medicine
Co-authored papers 6
Timothy D Girard
Clinical Research, University of Pittsburgh
Co-authored papers 6
Release 1.2